Gapping down
In reaction to earnings/guidance:
- ACCD -4.8%, IMOS -3.9% (Q3 revs) OSK -3.9% (lowers guidance) DS -2.2% (guides Q3 revs slightly below dual analyst estimate), ASX -1.7% (Sep revs)
Other news:
- ALLO -35.5% (FDA places hold on the company's AlloCAR T clinical trials)
- DXPE -3.1% (will require restatement to correct for the impact of aged un-vouchered purchase orders included in trade accounts payable and other immaterial prior-period items)
- RKLY -1.5% (stock offering)
Analyst comments:
- FAST -2.4% (downgraded to Underweight from Equal Weight at Wells Fargo)
- CAG -1.5% (downgraded to Neutral from Overweight at JP Morgan)
- CHTR -1.4% (downgraded to Underweight from Overweight at Wells Fargo)